Efficacy of biomarkers for predicting relapse in patients with ulcerative colitis with clinical remission: A single-center prospective study
Not Applicable
Recruiting
- Conditions
- lcerative Colitis
- Registration Number
- JPRN-UMIN000050963
- Lead Sponsor
- ational Hospital Organization Kure Medical Center and Chugoku Cancer Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
Not provided
Exclusion Criteria
1) Patients who are hospitalized 2) Patients with colostomy 3) Patients who are pregnant or may become pregnant 4) Patients who smoke 5) Patients with other inflammatory diseases 6) Patients receiving the following treatments within 4 weeks (a)NSAIDs (b)Aspirin (c)Budesonide rectal foam and enemas (d)Corticosteroids (e)Cytapheresis 7) Patients with malignant tumors (except after resection or remission) 8) Patients judged to be inappropriate for inclusion in this study
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method The sensitivity and specificity of biomarkers for clinical relapse in patients with ulcerative colitis with clinical remission.
- Secondary Outcome Measures
Name Time Method